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Does digital deliver?:
Full-field digital mammography for breast cancer screening 
and its possible advantages for imaging dense breast tissue
Kyle Oliver





Although medical physicists and radiologist have long suspected that the high contrast-
resolution of full-field digital mammography and the power of digital image 
manipulation have the potential to significantly improve mammographic screening of 
women with a significantly high proportion of dense breast tissue, early clinical studies 
on the detection accuracy of this technology did not show that its use offered significant 
advantages over traditional film mammography.  However, a very recent study in the 
New England Journal of Medicine has finally provided evidence of such an advantage. 
This paper discusses the basics of mammographic imaging and provides an overview of 
studies comparing digital mammography to film mammography, with particular emphasis 
on the challenges of imaging dense breast tissue, which is common in women under 50 
and women receiving hormone replacement therapy.
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Jemal et al. estimate that, in 2005, 32% of new cancer cases in American women will be 
from breast cancer.1  With such a high rate of breast cancer incidence, doctors 
recommend that all women over the age of forty get a yearly mammogram.  This creates 
the need for clinical practice that is reliable, quick, efficient, and cost effective.  As a 
former employee of a New York medical equipment company, the author became 
interested in workflow issues for busy radiology clinics.  He witnessed first-hand the 
disruptions caused to medium- and high-traffic clinics by equipment failures, especially 
failures of mammography equipment.  
However, mammography poses unique problems for busy clinics.  First, the 
Mammography Quality Standards Act of 1997 (MQSA) and its Reauthorization Acts of 
1998 and 2002 create regulations that have been deemed necessary to assure the quality 
of these procedures.  Though such regulations are surely proper, the demanding nature of 
these standards puts a strain on medical physicists and mammography technologists—
who must perform very frequent quality assurance (QA) testing—and equipment 
technicians—who must service these machines when they fail to operate as required, as 
they often do.
Second, because mammography is most often used as a screening technique, the vast 
importance of accurate breast imaging has slowed the adoption of digital detection
methods in this modality.  The Food and Drug Administration (FDA) only very recently 
approved the American College of Radiology (ACR) to accredit a full-field digital 
mammography (FFDM) unit—the Siemens Mammomat Novation DR.2 Even with such 
approval, though, the gains in adopting digital mammography are not as clear cut as for 
digital radiography in general.
This paper traces the development of FFDM (hereafter referred to as “digital 
mammography”) for screening purposes.  It first introduces some general principles of 
mammography and describes the imaging of two types of breast tissue: fatty and dense.  
Next, it discusses the advantages of performing screening mammography with digital
equipment.  Finally, it briefly assesses present recommendations about further adoption 
of digital mammography technology.
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Basics of screening mammography
At typical radiographic diagnostic energies, the Compton effect dominates photon 







Mammography is performed at lower energies, where the photoelectric effect also 
provides a significant contribution to photon attenuation.  The attenuation coefficient for 











Contrast is obtained in radiographic images because different structures in the body have 
different effective Z, Z/A, and ρ values.  Regions that scatter or absorb photons more 
effectively will allow fewer photons to penetrate the body and reach the film or detector.  
Obviously, the greater the differences in attenuation among various structures, the higher 
the contrast in the image obtained will be.
The principal problem with mammography is that, compared to bone or chest x-rays, the 
different structures being imaged in mammography have much more uniform 
composition and density.  Further complicating this modality, as noted by a quick survey 
of mammography articles in back issues of Medical Physics, is the need to reduce the 
radiation dose to the patient.  This is extremely important for a screening procedure that 
is recommended for a significant portion of the population on a regular basis; as Gur 
noted in 1978, “in mammography, it is the possible late induction of breast cancer that 
concerns us.”3
To keep doses low, x-ray tubes for mammography use a molybdenum-anode x-ray tube 
operated at roughly 25-28 kVp.  This tube produces a photon spectrum with peaks at 17.5 
and 19.6 keV.  Figure 1 shows the contributions of the photoelectric effect, the Compton 
effect (incoherent scattering), and the Rayleigh effect (coherent scattering) at low photon 
energies.  Note that the photoelectric effect provides a majority of the attenuation at 
mammography energies, but approximately 35% of the photons are still scattered, which 
reduces the signal-to-noise ratio and degrades the image.4
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Figure 1: Contribution of the photoelectric effect, Compton effect 
(incoherent scattering), and Rayleigh effect (coherent scattering) to 
scattering at low photon energies.  Mammography beams have
energies of approximately 15-20 keV.  (From Mammography: 
Introduction. (2003). Retrieved December 16, 2005, from Monash 
University Centre for X-ray Physics and Imaging Web site: 
http://cxpi.spme.monash.edu.au/index.htm)
As if these challenges were not great enough, some types of breast tissue are more 
difficult to image than others.  Although there is much variation in breast tissue 
composition from woman to woman, the most general classifications of tissue (and, as we 
will see, the most important from the perspective of evaluating digital versus film 
mammography) are fatty breast tissue and dense breast tissue.
Fatty breast tissue is the most common in older patients, who are at the greatest risk of 
breast cancer.  Fatty breast tissue is less dense than diseased tissue.  As seen in Equations 
1-2, both the photoelectric effect and Compton effect attenuation coefficients are linear 
functions of density.a  Thus, a higher percentage of photons penetrate the healthy tissue 
than the cancerous tissue.  This make a tumor show up as a light mass in the midst of the 
darker surrounding tissue.  Figure 2 shows a tumor within fatty breast tissue.
                                                
a For a rigorous treatment of x-ray transmission in the breast, see, for example, the Appendix of Sabol, J. M. 
& Plewes, D. B. (1996). Analytical description of the high and low contrast behavior of a scan-rotate 
geometry for equalization mammography. Medical Physics, 23(6), 887-898.
6
Figure 2: Mammogram of a tumor in fatty breast tissue.  The diseased 
tissue attenuates photons more effectively, so the tumor shows up light 
against a darker background of fatty tissue. (From Mammography: 
Introduction. (2003). Retrieved December 16, 2005, from Monash 
University Centre for X-ray Physics and Imaging Web site: 
http://cxpi.spme.monash.edu.au/index.htm)
Dense breast tissue is more common in younger women and women being treated with 
post-menopausal hormone replacement therapy.5  Unfortunately, dense breast tissue has a 
higher attenuation coefficient than fatty tissue—one much closer to the coefficient of 
cancerous tissue.  This effect is evident in comparing Figure 2 with Figure 3, which 
shows a much more “opaque” mammogram of a dense breast.
Figure 3: Mammogram of a dense breast.  Comparison with Figure 2 
suggests the much greater relative difficulty of spotting a tumor in dense 
breast tissue. (From Mammography: Introduction. (2003). Retrieved 
December 16, 2005, from Monash University Centre for X-ray Physics 
and Imaging Web site: http://cxpi.spme.monash.edu.au/index.htm)
Unfortunately, the tumors that dense breast tissue may hide are often a good deal more 
dangerous than the comparatively easy to find ones in fatty breast tissue.  While cancer 
rates are higher in older women, who tend to have fatty breast tissue, Buist et al. report 
that higher breast densities not only obscure tumors, they also increases a younger 
woman’s risk of developing breast cancer compared to same-aged women with less dense 
7
breast tissue.  In addition, oncologists believe tumors in dense breast tissue grow more 
quickly than those in fatty tissue.6
Though logic and the theoretical principles of medical physics only predict the 
differences between dense and fatty breast mammography described above, the 
consequences of these differences have been experimentally verified through a number of 
clinical studies.  The most comprehensive was a study by Carney, et al.  They attempted 
to determine “how breast density, age, and use of [hormone replacement therapy] 
individually and in combination affect the accuracy of screening mammography.”  They 
studied 329,495 women who had mammograms between 1996 and 1998.  This study 
used data submitted to the National Cancer Institute’s Breast Cancer Surveillance 
Consortium by seven different states.  The researchers excluded patients receiving 
diagnostic mammography procedures, patients with incomplete records, and patients with 
breast implants.7
Table 1 shows their data regarding the breast densities of the women studied, divided by 
age group and whether or not the patient was receiving hormone replacement therapy.
Table 1: Breast density data, divided by age group and
hormone replacement therapy status, from Carney, et al. study
These data clearly show that the probability of a woman having dense breast tissue
decreases as a function of age and that older women receiving hormone replacement 
therapy are more likely to have dense breast tissue than older women not receiving such 
therapy.  These data are important because they allowed the researchers to measure the 
effects of the presence of dense breast tissue on mammography screening accuracy.  
Table 2 shows the overall study results.
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Table 2: Overall results of Carney et al. study
In particular, note the high false negative rates for women with heterogeneously dense 
and extremely dense breast tissue and the low sensitivity of screening mammography for 
women aged 40-49 and for women with heterogeneously dense and extremely dense 
breast tissue.  With its large sample size and carefully controlled methodology, Carney et 
al.’s conclusion that “mammographic breast density, [hormone replacement therapy] use, 
and age were all important predictors of the accuracy of screening mammography” is 
well founded.8  Studies by Buist et al.9 and Kerlikowske et al.10 further confirmed these 
results.
Thus, physical analysis and clinical experience both suggested that measures needed to 
be taken to improve screening mammography accuracy for women with dense breast 
tissue, especially young women and women on hormone replacement therapy.  The next 
section will, in part, discuss the role of digital mammography in facilitating that 
improvement.
Digital mammography as a solution to the challenges of 
imaging dense breast tissue
A thorough discussion of the advantages and disadvantages of both film and digital 
mammography was provided by Feig and Yaffe in 1998.  They first noted the obvious 
advantage that, in digital mammography, separate components perform the duties of 
“image acquisition, storage, and display,” whereas film bears the responsibility for all of 
these functions in film mammography.11  Thus, digital equipment can be optimized to 
perform each of these various tasks.  Figure 4 shows their schematic process diagrams for 
film and digital mammography.
9
Figure 4: Schematic diagram of film (left) and digital (right) mammography processes.  
Note that film bears the responsibility of image acquisition, storage, and display.  (From 
Feig, S. A. & Yaffe, M. J. (1998). Digital mammography. Radiographics, 18, 893-901.)
The digital equipment customized to each task gives digital mammography several 
advantages.  First, Feig and Yaffe note, digital detectors have a much wider dynamic 
range, and they have a linear response curve because the size of the electronic signal from 
the detector is a linear function of exposures.b  Even more important, however, is the 
ability to perform digital image manipulation without the need to digitize the film with a 
scanner.12
Figure 5 shows the possible benefits of digital image manipulation.  Recall Figures 1-2, 
which compared tumor images in fatty and dense breast tissue.  Figure 5 shows how 
digital mammography can help bring tumors in dense breast tissue closer to tumors in 
fatty breast tissue with respect to ease of detection.  The figure shows the unaltered image 
of a dense breast and the same breast with an inset region of interest where digital image 
enhancement darkens the background and makes a tumor in the dense tissue more visible.  
                                                
b The density-exposure curves of film have a more complicated dependence.  See Feig and Yaffe, p. 894.
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Figure 5: Two mammograms of a dense breast.  The inset at right 
has been altered with digital image enhancement, in this case 
darkening the bright dense tissue background so that the 
underlying tumor can be seen.  (From Feig, S. A. & Yaffe, M. J. 
(1998). Digital mammography. Radiographics, 18, 893-901.)
These images, combined with the improved intrinsic contrast resolution in digital 
mammography,13 suggest the benefits of the technique for screening young women, 
women with particularly dense breasts, and women on hormone replacement therapy.  
However, these results were only suggestive.  Lewin, et al. summarize the main source of 
uncertainty in speculating on the different detection capabilities of digital and film thusly: 
“Compared with film, the digital detector has greater contrast resolution…However, the 
digital detector does not have as high a spatial resolution for high-contrast objects as film 
does, and the effect on cancer detection of this trade-off between spatial resolution and 
contrast resolution cannot be predicted, because both play a role in revealing the features 
of breast cancers.”14
Thus, digital mammography showed promise, but still had to prove itself on two key 
points: (1) it had to be shown to be just as reliable for general use as film mammography,
and (2) it had to demonstrate a significant advantage over film mammography for certain 
demographics (e.g., women with dense breasts).
While acknowledging the potential benefits of digital mammography, one medical 
physics study, performed by Kuzmiak, et al., was not particularly reassuring with respect 
to the performance of digital mammography versus film.  The researchers studied 
phantom object detection for both techniques.  They found that digital systems did not 
have a higher phantom object detection rate than film systems, and for two of the systems 
studied (models made by Fischer and and Spectra), the object detection rate for digital 
was actually worse than for a standard film system, and that difference was statistically 
significant.15  Far from showing that digital was an improvement over film, these results 
do not even suggest that digital is as effective.
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However, these results are tempered by several observations.  Most importantly, the 
study used a film scanner to digitize the film results.  Thus, the improved detection from 
the film system may have been partially the result of the benefits of digital image 
manipulation.  In clinical settings, few screening mammograms are scanned in a viewed 
in this “soft copy” form, so this benefit would not be born out in practice.  Second, 
although this study did utilize phantoms simulating increasingly dense breasts and found 
no improvement in the digital systems’ ability to image them, density was not the 
variable of interest in this experiment.  An experimental design more specifically tailored 
to studying the effect of tissue density on object detection may have yielded different 
results.
Of course, it is in the clinic that screening digital mammography must ultimately prove 
itself versus film, and the results of these studies have been more favorable for digital 
systems than the study by Kuzmiak, et al.  Four large clinical trials that compared film to 
digital screening mammography showed little to no difference between digital and film 
systems for studies of the general public.
Lewin has performed two such studies with other researchers.  The first studied 4,945 
women over 40 who received mammograms at one of two participating institutions.  The 
researchers chose a sample population of screening patients, rightly pointing out that 
earlier studies—performed to aid manufacturers in obtaining FDA approval of the FFDM 
equipment—had probably introduced bias by analyzing a group of patients who were 
receiving diagnostic mammography procedures; these procedures receive much more 
time and attention from radiologists, and do not fairly test the detection accuracy of 
mammography equipment in its much more common deployment as a screening tool.
Eligibility for the study required women to be at least 40 years old, to be breast implant-
free, and to have breasts that could be completely imaged on a 24 cm x 30 cm detector.  
The women who participated had a digital and a film mammogram taken within three 
days (91% of them had the procedures on the same day, with the same technologist).  
This study concluded that there was no statistically significant difference between digital 
and film screening mammography in terms of detection rate.16  Another, larger study by 
Lewin, et al. reached the same conclusions.17  Two studies in Oslo, Norway, also found 
no statistically significant difference between detection rates in screening populations for 
digital and film systems, and these studies included roughly 10 times the participants.18,19
On the whole, these studies suggest that digital mammography probably meets the first 
criterion of performing at least as well as film units for screening mammography.  
However, until very recently, there was really no evidence of a reason to switch to digital 
mammography.  After all, as will be discussed later, the cost of making this switch is by 
no means insignificant.  Thus, as Dershaw rightly points out, some kind of significant
gains must be demonstrated before most hospitals and clinics will seriously begin to think 
about adding digital mammography capability, let alone switching to its exclusive use.20
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A couple months ago, a study in the New England Journal of Medicine provided 
convincing evidence of such gains.  The study there reported was performed by Pisano, et 
al. for the Digital Mammographic Imaging Screening Trail (DMIST).  This was a huge 
study, analyzing data from 49,333 eligible asymptomatic patients who received both 
digital and film mammograms at one of 33 participating sites.  These mammograms were 
each read by two radiologists.
Of all of the participants studied, 42,760 had verifiable cancer status at the end of the two 
year study.  This status was carefully defined; women were classified as positive for 
cancer if, within 455 days of screening, pathology tests confirmed that the cancer 
identified in the screening mammogram was present.  They were confirmed as being 
cancer negative if pathology tests of possible tumor masses from the mammographic 
screening were negative and/or if a one-year follow up mammogram was read as normal 
by the radiologists.  Table A-1 in the Appendix summarizes the demographic information 
both for all the participants in the study and those whose cancer status was confirmed 
within its time constraints.
Once again, this study concluded that, for the general population, there are no significant 
gains to be had from either technology.  However—and this was the evidence that had 
been searched for for quite some time—the study did find that digital mammography was 
a more effective screening tool for women under the age of 50.  As stated by the authors, 
“The performance of digital mammography was…significantly better than that of film 
mammography among women under the age of 50 years…, women classified by the 
readers as having heterogeneously dense or extremely dense breasts…, and 
premenopausal or perimenopausal women.”21
This is best illustrated by Figure 6, which plots sensitivity—the ability of a mammogram 
to correctly identify the presence of breast cancer—versus specificity—the ability to 
correctly identify the non-presence of breast cancer—for several different demographics.
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Figure 6: Sensitivity versus specificity in for digital and film mammography for 
patients with confirmed cancer status, divided by demographic. (From Pisano, E. 
D., et al. (2005). Diagnostic performance of digital versus film mammography for 
breast-cancer screening. New England Journal of Medicine, 353(17), 1773-1783.)
These estimates of specificity and sensitivity are based on the Breast Imaging Reporting 
and Data System (BIRADS) standard seven-point malignancy scale, which the 
participating radiologists all received training in.22  They support the authors’ conclusion 
that screening with digital mammography is more effective for the demographics shown 
in plots B, C, and D in Figure 6.c Greater sensitivity for a given specificity means 
significantly more present tumors were identified in patients from these demographics 
with the digital systems, which should be the goal of any improvement to the breast 
cancer screening system.  
                                                
c The relevant data are presented in greater detail in Table 2-A of the Appendix.
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Although medical physicists and radiologists had suspected this was the case for years, 
this study represents the first reasonably conclusive proof.   Although all previous studies 
yielded very equivocal results, the enormous scope of this study, and its superior 
experimental methodology—designed, as it was, to account for flaws in earlier clinical 
trials23—should assuage any doubts about its results.  Thus, there are now reasonable 
grounds to motivate a field-wide discussion about how best to implement digital 
mammographic imaging into this country’s screening system.
Conclusions and recommendations
In an editorial published simultaneously with the DMIST study, Dershaw perceptively 
defined the terms of this discussion.  After praising the results of the study, he 
summarized the very significant barriers to acting on them:
These advantages must be weighed against the cost of digital-imaging 
systems, which are often one and one half to four times as expensive as 
film mammography systems. Women with large breasts who undergo 
digital mammography may require multiple exposures to ionizing 
radiation because the smaller image size requires the acquisition of 
multiple images to image the breast fully. Workstations for viewing digital 
mammograms are frequently not user-friendly and more time and effort 
are often required to read digital mammograms than film mammograms. It 
can also be difficult to compare digital images with older film studies.24
Dershaw is quite right to point out these problems, and DMIST is currently conducting a 
study on the cost-effectiveness of implementing more digital mammography within the 
breast cancer screening system.  As an erstwhile x-ray and mammography equipment 
technician and observer of the everyday operations in many New York hospitals and 
radiology clinics (some of them extremely busy and efficient ones), this author hopes and 
suspects that decision-makers currently considering whether to increase their capacity for 
digital mammography screening will answer in the affirmative.
First, while “workstations for viewing digital mammograms” may not be user-friendly at 
present, increased demand for these systems will eventually drive market forces to 
improve these workstations.  Bioinformatics is a growing field that is getting better and 
better at keeping pace with technological improvements on the hardware side of medical 
imaging.  Though this will require the commitment of resources—and, more importantly, 
responsiveness to customer feedback—on part of equipment and software manufacturers, 
the current state of digital workstations should not unduly influence the future of digital 
mammography in this country.
Second, while mammography procedures performed with digital equipment may take 
much longer to perform and read than their film equivalents now, this state is also 
unlikely to persist as technologists and radiologists become more adept with these 
procedures.  Though they may not, in the end, end up being any faster than film, digital 
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techniques will undoubtedly get faster and may approach equivalent film system speeds.  
Again, the point is that it is too early to tell, and current imaging and reading times 
should not be assumed to be constant.
Third, increasingly efficient clinics are demonstrating the serious benefits of going all 
digital and implementing facility-wide PACS systems.  Provided that studies continue to 
show no medical detriment to using digital images for mammographic screening, it will 
be important for mammography departments to consider digital systems so as not to be 
left out of the digitalization process.
However, this is no denying that the hurdles of going digital are still significant, despite 
the above points.  For a procedure with already low reimbursement values, the burden of 
spending several times current costs for digital mammography equipment cannot be 
ignored.  Furthermore, Pisano et al. note that, unlike women with mostly dense breast 
tissue, women with mostly fatty breast tissue might still be better served by film.25  
Obviously, these women—who are, on average, at higher risk for breast cancer—need to 
be screened as effectively as possible.  
But, if it financially possible, so should women with mostly dense breast tissue.  Thus, in 
this author’s opinion, Dershaw’s recommendation that hospitals and clinics cautiously 
proceed with the process of gradually supplementing their film mammography screening 
capabilities with digital ones is the best course of action at this time.  Doing so will help 
mammography departments stay connected with the general trend of increased 




Table A-1: Demographic information for patients in
Pisano, et al. study performed by DMIST
17
Table 2-A: Pathological information for referred women by type of mammography
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